These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23925734)

  • 1. Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats.
    Mohler EG; Franklin SR; Rueter LE
    Psychopharmacology (Berl); 2014 Jan; 231(1):67-74. PubMed ID: 23925734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.
    Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M
    Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
    Smith JW; Mogg A; Tafi E; Peacey E; Pullar IA; Szekeres P; Tricklebank M
    Psychopharmacology (Berl); 2007 Feb; 190(2):157-70. PubMed ID: 17115136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
    Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
    Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
    Jutkiewicz EM; Brooks EA; Kynaston AD; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):194-202. PubMed ID: 21730011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors.
    Olsen JA; Kastrup JS; Peters D; Gajhede M; Balle T; Ahring PK
    J Biol Chem; 2013 Dec; 288(50):35997-6006. PubMed ID: 24169695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α4β2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of α4β2 nAChR agonists in pain.
    Lee CH; Zhu C; Malysz J; Campbell T; Shaughnessy T; Honore P; Polakowski J; Gopalakrishnan M
    Biochem Pharmacol; 2011 Oct; 82(8):959-66. PubMed ID: 21763685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
    Liu X
    Psychopharmacology (Berl); 2013 Nov; 230(2):203-13. PubMed ID: 23712602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
    Zhu CZ; Chin CL; Rustay NR; Zhong C; Mikusa J; Chandran P; Salyers A; Gomez E; Simler G; Lewis LG; Gauvin D; Baker S; Pai M; Tovcimak A; Brown J; Komater V; Fox GB; Decker MW; Jacobson PB; Gopalakrishnan M; Lee CH; Honore P
    Biochem Pharmacol; 2011 Oct; 82(8):967-76. PubMed ID: 21620806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
    Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
    J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
    Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
    Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropharmacological modulation of the P3-like event-related potential in a rat two-tone auditory discrimination task with modafinil and NS9283, a positive allosteric modulator of α4β2 nAChRs.
    Grupe M; Grunnet M; Laursen B; Bastlund JF
    Neuropharmacology; 2014 Apr; 79():444-55. PubMed ID: 24361451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice.
    Tobey KM; Walentiny DM; Wiley JL; Carroll FI; Damaj MI; Azar MR; Koob GF; George O; Harris LS; Vann RE
    Psychopharmacology (Berl); 2012 Sep; 223(2):159-68. PubMed ID: 22526534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.
    Freitas K; Carroll FI; Negus SS
    Exp Clin Psychopharmacol; 2016 Feb; 24(1):65-75. PubMed ID: 26461167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine-like discriminative and aversive effects of two α4β2-selective nicotine agonists, ispronicline and metanicotine.
    Winger G
    Behav Pharmacol; 2021 Sep; 32(6):497-504. PubMed ID: 34320519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
    Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential discriminative-stimulus effects of cigarette smoke condensate and nicotine in nicotine-discriminating rats.
    Lee JY; Choi MJ; Choe ES; Lee YJ; Seo JW; Yoon SS
    Behav Brain Res; 2016 Jun; 306():197-201. PubMed ID: 26996314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.